ºÚÁÏÍø

Journal of Tuberculosis and Therapeutics
ºÚÁÏÍø

Pulmonary Tuberculosis

Search results for
Pulmonary Tuberculosis

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Pulmonary Tuberculosis

It occurs to the upper lobe of the right lung. Mycobacterium grow at high levels of oxygen and blood thus it effects lungs, and later on passes to other part of the body called as extrapulmonary tuberculosis. It is potentially deadly disease but it can be cured by medical help. Most of the people recover with primary TB. The infection may stay inactive for years, and it may become active again.

Pulmonary Tuberculosis

Expert PPTs

Speaker PPTs

  • Shoude Jin
    Mechanisms of Chronic obstructive pulmonary disease and airway smooth muscle remodeling: the potential roles of Abhd2
    | PDF Version
  • Alsayed Alnahal
    Urinary netrin-1 predict early ischemic acute kidney injury after cardiopulmonary bypass
    | PDF Version
  • Ping Yang
    Chronic obstructive pulmonary disease (COPD) complicating early-stage lung cancer (LC)
    | PDF Version
  • Gunilla Lindqvist
    Chronic obstructive pulmonary disease: A study of the relationship between patients’ feeling of guilt due to their belief of the disease being self inflicted
    | PDF Version
  • Roger Mark Engel
    The effect of including manual therapy in the management of mild chronic obstructive pulmonary disease – a randomized controlled trial
    | PDF Version
  • Rupal Patel Mansukhani
    Correlation of Medication Therapy in Chronic Obstructive Pulmonary Disease(COPD) Patients with 30-day Readmission Rates
    | PDF Version
  • Zakaria Hmama
    A non-genetic approach to improve the tuberculosis vaccine BCG
    | PDF Version
  • Hadeel Faisal Gad
    In-vitro analysis of cytokines responses of visceral leishmaniasis and pulmonary tuberculosis patients to homologous and heterologous antigen stimulation
    | PDF Version
  • Rinat Islamov
    Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
    | PDF Version
  • Akujobi Comfort
    Multi drug-resistant tuberculosis (MDR-TB) among HIV positive patients in a tertiary institution in south eastern Nigeria
    | PDF Version
  • Helmi Mardassi
    A ten-year evolution of a multidrug-resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011)
    | PDF Version
  • Xin Wang
    IL17 Pathway Involves Moderating Pulmonary Hypertension, a common complication of COPD, in Statins Therapy in Smoking Rats
    | PDF Version
  • Takalani Tshitangano
    The management of health care workers’ latent tuberculosis infection at hospitals of Vhembe district
    | PDF Version
  • Abu Salim Mustafa
    Diagnostic potential of M. tuberculosis-specific proteins and peptides
    | PDF Version
  • Syed Khajamohiddin
    Engineering of cytochrome P450 monooxygenases-based novel inhibitors against Mycobacterium tuberculosis
    | PDF Version
High Impact List of Articles
Conference Proceedings